← FDA DRUG APPROVALS

FDA ANDA · ANDA083077

PROPOXYPHENE COMPOUND 65

Sponsor: IVAX SUB TEVA PHARMS

APPLICATION
ANDA083077
TYPE
ANDA
ORIGINAL APPROVAL
1978-04-14
LATEST ACTION
1978-04-14
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

PROPOXYPHENE COMPOUND 65Discontinued
ASPIRIN 389MG, CAFFEINE 32.4MG, PROPOXYPHENE HYDROCHLORIDE 65MG · CAPSULE · ORAL

Approval history

1978-04-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →